HighMark Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
HighMark Wealth Management's HALO Position: Q3 2025 in Review
HighMark Wealth Management sold out of Halozyme (HALO) in Q3 2025, closing a stake of 30 shares — an estimated $1.56K sold.
HighMark Wealth Management first reported a position in HALO in Q2 2020 and held it in 20 quarters. The position peaked at $2.43M in Q2 2021. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.
- HighMark Wealth Management reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
- HighMark Wealth Management sold 30 Halozyme shares in Q3 2025, an estimated $1.56K.
- HighMark Wealth Management first reported a position in Halozyme in Q2 2020 and held it in 20 quarters.
- HighMark Wealth Management's Halozyme position peaked at $2.43M in Q2 2021.
- 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.
Based on HighMark Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.